Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.
Jessica S LittleRebekah M DedrickKrista G FreemanMadison CristinzianoBailey E SmithConstance A BensonTulip A JhaveriLindsey R BadenDaniel A SolomonGraham F HatfullPublished in: Nature communications (2022)
Mycobacterium chelonae is a rare cause of chronic disseminated cutaneous infections in immunocompromised patients. Multidrug-resistant M. chelonae infections present a challenge for treatment, and prolonged antimicrobial courses lead to significant toxicities and further antimicrobial resistance. We report a case of refractory cutaneous disseminated M. chelonae infection in a patient with seronegative arthritis on immunotherapy with tofacitinib that was treated with combination antimicrobial, surgical, and single bacteriophage therapy with excellent clinical response. The patient developed neutralizing antibodies against the bacteriophage but continues to have stable improvement of disease with negative biopsies and no evidence of bacterial resistance to the phage.
Keyphrases
- antimicrobial resistance
- multidrug resistant
- rheumatoid arthritis
- staphylococcus aureus
- end stage renal disease
- newly diagnosed
- case report
- mycobacterium tuberculosis
- ejection fraction
- peritoneal dialysis
- pseudomonas aeruginosa
- intensive care unit
- drug resistant
- escherichia coli
- combination therapy
- smoking cessation
- zika virus
- replacement therapy
- acute respiratory distress syndrome
- ulcerative colitis
- respiratory failure
- klebsiella pneumoniae